- Report
- August 2020
- 122 Pages
Global
From €4334EUR$4,450USD£3,705GBP
- Report
- April 2022
- 212 Pages
Global
From €3506EUR$3,600USD£2,998GBP
- Report
- April 2022
- 95 Pages
Middle East, Africa
From €1461EUR$1,500USD£1,249GBP
- Report
- May 2022
- 324 Pages
Global
From €3506EUR$3,600USD£2,998GBP
- Report
- May 2022
- 110 Pages
Europe
From €1461EUR$1,500USD£1,249GBP
- Report
- May 2022
- 96 Pages
North America
From €1461EUR$1,500USD£1,249GBP
- Report
- November 2021
- 545 Pages
Global
From €3896EUR$4,000USD£3,331GBP
- Report
- November 2021
- 1165 Pages
Global
From €5844EUR$6,000USD£4,996GBP
- Report
- November 2021
- 233 Pages
Global
From €2435EUR$2,500USD£2,082GBP
- Report
- March 2022
- 286 Pages
Global
From €5619EUR$5,769USD£4,804GBP
- Report
- September 2019
Global
From €5230EUR$5,370USD£4,471GBP
- Report
- March 2019
- 230 Pages
Global
From €5230EUR$5,370USD£4,471GBP
- Book
- February 2024
- 160 Pages
- Book
- January 2022
- 336 Pages
- Book
- September 2019
- 1224 Pages
- Book
- April 2010
- 512 Pages
The Genotype market is a subset of the genomics industry that focuses on the analysis of genetic variation. It involves the use of genetic testing to identify and characterize genetic variants, such as single nucleotide polymorphisms (SNPs), which can be used to identify individuals and predict their risk of developing certain diseases. Genotype testing is used in a variety of applications, including clinical diagnostics, drug development, and personalized medicine.
The genotype market is a rapidly growing industry, driven by advances in technology and the increasing availability of genetic data. Companies in the genotype market are developing new technologies and services to enable the analysis of genetic variation and to provide insights into the genetic basis of disease. Examples of companies in the genotype market include 23andMe, Illumina, and Thermo Fisher Scientific. Show Less Read more